2020 Leadership Journey Project: Affordable, Available, and Administrable therapeutics for COVID-19 – A review of ‘Triple A’ candidate drugs in clinical development and with potential for equitable and global impact.
Dr. Michelle Hsiang is an Assistant Professor in pediatric infectious diseases at the University of Texas, Southwestern with a research focus in malaria elimination epidemiology and clinical research evaluating novel diagnostic, surveillance, and drug-based strategies, such as targeted mass drug administration, in Asia and Africa. She has also supported national governments, regional efforts, and global consensus building in malaria elimination efforts. She has supported several countries in their strategic planning from control to elimination, co-founded the Asia Pacific Malaria Elimination Network (APMEN), and has served on advisory committees including the Malaria Elimination Group (MEG) and WHO expert review groups. She is Associate Director of Operational Research with the Malaria Elimination Initiative at the University of California, San Francisco (UCSF), Global Health Group.
Dr. Hsiang also holds appointments as Assistant Adjunct Professor in Pediatrics at UCSF and at University of Texas School of Public Health. Dr. Hsiang completed her undergraduate training at Stanford University. She received her MD at Baylor College of Medicine, completed a residency in Pediatrics and fellowship in Pediatric Infectious Diseases at UCSF, and received a Masters in Epidemiology from London School of Hygiene and Tropical Medicine.